BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3568448)

  • 1. A comparison of leukocyte aggregation, leukocyte migration and skin reactivity to recall antigens in patients with AIDS.
    Rouveix B; Groult F; Pocidalo JJ
    Clin Exp Immunol; 1986 Dec; 66(3):574-81. PubMed ID: 3568448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I/II trial of recombinant interleukin-2 in AIDS/ARC: alterations of phenotypes of peripheral blood mononuclear cells.
    Flad HD; Ernst M; Kern P
    Lymphokine Res; 1986; 5 Suppl 1():S171-6. PubMed ID: 3491258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D
    Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
    Szczylik C; Wiktor-Jedrzejczak W
    Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic laboratory tests in acquired immunodeficiency syndrome (AIDS) and suspected AIDS].
    Joller-Jemelka HI; Vogt M; Joller PW
    Schweiz Med Wochenschr; 1985 Jan; 115(4):125-32. PubMed ID: 3156402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte migration inhibition (LMI) by a specific antigen in human toxoplasmosis.
    Ferencz A; Nyerges G; Jankó M
    Acta Microbiol Acad Sci Hung; 1982; 29(3):209-11. PubMed ID: 7168371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation.
    Repo H; Kostiala AA; Kosunen TU
    Clin Exp Immunol; 1980 Feb; 39(2):442-8. PubMed ID: 6993072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivity.
    Geczy CL; Meyer PA
    J Immunol; 1982 Jan; 128(1):331-6. PubMed ID: 6172485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity against digestive organ cancers : leucocyte migration inhibitory factor activity as an immunological parameter.
    Hamasaki K
    Acta Med Okayama; 1977 Jun; 31(3):147-59. PubMed ID: 144415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeated delayed hypersensitivity skin tests on skin-test responses.
    Christou NV; Pietsch JB; Meakins JL
    Can J Surg; 1983 Mar; 26(2):139-42. PubMed ID: 6825002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between immunological stage and response to chemotherapy. Results in 64 patients with nonresectable epidermoid bronchial cancers].
    Pouillart P; Botto G; Gauthier H; Huguenin P; Baron A; Laparre C; Hoang Thy HT; Parrot R; Mathé G
    Nouv Presse Med; 1976 Apr; 5(16):1037-42. PubMed ID: 1272771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced delayed hypersensitivity skin test reactivity with serial testing in healthy volunteers.
    Keystone EC; Demerieux P; Gladman D; Poplonski L; Piper S; Buchanan R
    Clin Exp Immunol; 1980 Apr; 40(1):202-5. PubMed ID: 6993077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immunity in chronic polymorphous light eruptions. Leukocyte migration inhibition assay with irradiated skin as antigen.
    Jansén CT; Helander I
    Acta Derm Venereol; 1976; 56(2):121-5. PubMed ID: 58520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meaning of leukocyte migration inhibition in the presence of soluble antigens].
    Clot J; Mandin J
    Ann Inst Pasteur (Paris); 1972 Jul; 123(1):121. PubMed ID: 4640715
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of Amplicor HIV-1 test for detection of human immunodeficiency virus type 1 proviral DNA in peripheral blood mononuclear cells.
    Khadir A; Coutlée F; Saint-Antoine P; Olivier C; Voyer H; Kessous-Elbaz A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):257-63. PubMed ID: 7788424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of clinical significance of leukocyte migration inhibition test in drug-induced hypersensitivity pneumonitis].
    Uno K; Kondo A
    Arerugi; 1995 Dec; 44(12):1401-9. PubMed ID: 8871295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cellular immunity: in vitro leukocyte migration inhibition does not correlate with the tuberculin skin test].
    Hofmann E; Sauter C; Reinhardt E
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1376-8. PubMed ID: 482909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of penicillin allergy. An evaluation of the leucocyte aggregation test in man.
    Levacher M; Rouveix B; Badenoch-Jones P
    Clin Allergy; 1983 Jan; 13(1):21-9. PubMed ID: 6339114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.